Alzinova AB (ALZ) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.047x

Based on the latest financial reports, Alzinova AB (ALZ) has a cash flow conversion efficiency ratio of 0.047x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr5.78 Million ≈ $621.81K USD) by net assets (Skr121.96 Million ≈ $13.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Alzinova AB net asset quality index to measure how much of total assets are equity-financed.

Alzinova AB - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Alzinova AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow reinvestment rate of Alzinova AB to assess the company's total reinvestment commitment from operating cash flow.

Alzinova AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alzinova AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Outback Goldfields Corp V:OZ	-0.040x
IXUP Ltd AU:IXU	-0.742x
Latrobe Magnesium Limited F:L2Q	0.064x
Indian Terrain Fashions Limited NSE:INDTERRAIN	0.029x
Trigyn Technologies Limited NSE:TRIGYN	-0.080x
Helport AI Limited Ordinary Shares NASDAQ:HPAI	N/A
GeneMatrix Inc KQ:109820	0.027x
DATRIX S.P.A. F:BW6	N/A

Annual Cash Flow Conversion Efficiency for Alzinova AB (2014–2025)

The table below shows the annual cash flow conversion efficiency of Alzinova AB from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Alzinova AB market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr121.96 Million ≈ $13.12 Million	Skr-13.03 Million ≈ $-1.40 Million	-0.107x	+34.72%
2024-12-31	Skr123.82 Million ≈ $13.33 Million	Skr-20.27 Million ≈ $-2.18 Million	-0.164x	-22.49%
2023-12-31	Skr113.86 Million ≈ $12.25 Million	Skr-15.21 Million ≈ $-1.64 Million	-0.134x	-36.72%
2022-12-31	Skr105.53 Million ≈ $11.36 Million	Skr-10.31 Million ≈ $-1.11 Million	-0.098x	+11.95%
2021-12-31	Skr88.47 Million ≈ $9.52 Million	Skr-9.82 Million ≈ $-1.06 Million	-0.111x	-70.10%
2020-12-31	Skr96.02 Million ≈ $10.33 Million	Skr-6.27 Million ≈ $-674.29K	-0.065x	+2.98%
2019-12-31	Skr59.11 Million ≈ $6.36 Million	Skr-3.98 Million ≈ $-427.85K	-0.067x	-8.08%
2018-12-31	Skr63.75 Million ≈ $6.86 Million	Skr-3.97 Million ≈ $-426.95K	-0.062x	+14.16%
2017-12-31	Skr29.39 Million ≈ $3.16 Million	Skr-2.13 Million ≈ $-229.31K	-0.072x	+16.33%
2016-12-31	Skr31.90 Million ≈ $3.43 Million	Skr-2.76 Million ≈ $-297.46K	-0.087x	+44.29%
2015-12-31	Skr20.63 Million ≈ $2.22 Million	Skr-3.21 Million ≈ $-345.40K	-0.156x	+66.23%
2014-12-31	Skr1.55 Million ≈ $167.09K	Skr-715.19K ≈ $-76.97K	-0.461x	--

About Alzinova AB

ST:ALZ Sweden Biotechnology

Market Cap

$18.28 Million

Skr169.84 Million SEK

Market Cap Rank

#25355 Global

#521 in Sweden

Share Price

Skr1.10

Change (1 day)

-5.52%

52-Week Range

Skr0.40 - Skr2.03

All Time High

Skr26.90